Stonepine Capital Management’s Avalo Therapeutics AVTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-524	Closed	-$2.57M	–	30
2021 Q4	$2.57M	Buy	524 +229	+78%	+$1.12M	1.18%	18
2021 Q3	$1.85M	Buy	+295	New	+$1.85M	0.84%	19
2020 Q3	–	Sell	-156	Closed	-$1.17M	–	18
2020 Q2	$1.17M	Buy	+156	New	+$1.17M	2.27%	11